Weight Change as a Predictor of Incidence and Remission of Insulin Resistance

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Chang, Yoosoo ^a   Sung, Eunju ^a   Yun, Kyung Eun ^a   Jung, Hyun Suk ^a   Kim, Chan Won ^a   Kwon, Min Jung ^a   Cho, Sung Il ^b   Ryu, Seungho ^a  

^a Sungkyunkwan University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; COMPUTER MODEL; CONTROLLED STUDY; FOLLOW UP; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; MORBIDITY; REMISSION; WEIGHT CHANGE;

ADULT; BODY MASS INDEX; BODY WEIGHT; COHORT STUDIES; HUMANS; INCIDENCE; INSULIN; INSULIN RESISTANCE; KOREA; MALE; METABOLIC SYNDROME X;

EID: 84878030168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063690     Document Type: Article

References (43)

1. Weyer C, Bogardus C, Mott DM, Pratley RE, (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. The Journal of clinical investigation 104: 787-794.
2. Reaven GM, (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
3. Verhagen SN, Wassink AM, van der Graaf Y, Gorter PM, Visseren FL, (2011) Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study. Cardiovascular diabetology 10: 100.
4. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, et al. (2007) Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes care 30: 318-324.
5. Petridou ET, Sergentanis TN, Antonopoulos CN, Dessypris N, Matsoukis IL, et al. (2011) Insulin resistance: an independent risk factor for lung cancer? Metabolism: clinical and experimental 60: 1100-1106.
6. Kahn SE, Hull RL, Utzschneider KM, (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846.
7. Conus F, Rabasa-Lhoret R, Peronnet F, (2007) Characteristics of metabolically obese normal-weight (MONW) subjects. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 32: 4-12.
8. Tam CS, Viardot A, Clement K, Tordjman J, Tonks K, et al. (2010) Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans. Diabetes 59: 2164-2170.
9. Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, et al. (2008) Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol Endocrinol Metab 294: E568-575.
10. Samocha-Bonet D, Campbell LV, Mori TA, Croft KD, Greenfield JR, et al. (2012) Overfeeding reduces insulin sensitivity and increases oxidative stress, without altering markers of mitochondrial content and function in humans. PLoS One 7: e36320.
11. Everson SA, Goldberg DE, Helmrich SP, Lakka TA, Lynch JW, et al. (1998) Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care 21: 1637-1643.
12. Lakka HM, Salonen JT, Tuomilehto J, Kaplan GA, Lakka TA, (2002) Obesity and weight gain are associated with increased incidence of hyperinsulinemia in non-diabetic men. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 34: 492-498.
13. Gumbs AA, Modlin IM, Ballantyne GH, (2005) Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obesity surgery 15: 462-473.
14. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, et al. (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. The American journal of medicine 122: 248-256 e245.
15. Padwal RS, (2009) Review: bariatric surgery reduces weight and improves type 2 diabetes in adults. Evidence-based medicine 14: 138.
16. Kumar AA, Palamaner Subash Shantha G, Kahan S, Samson RJ, Boddu ND, et al. (2012) Intentional weight loss and dose reductions of anti-diabetic medications-a retrospective cohort study. PLoS One 7: e32395.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
18. Wallace TM, Levy JC, Matthews DR, (2004) Use and abuse of HOMA modeling. Diabetes care 27: 1487-1495.
19. Levy JC, Matthews DR, Hermans MP, (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes care 21: 2191-2192.
20. Ryu S, Chang Y, Zhang Y, Kim SG, Cho J, et al. (2012) A cohort study of hyperuricemia in middle-aged South Korean men. American journal of epidemiology 175: 133-143.
21. Chang Y, Ryu S, Sung E, Jang Y, (2007) Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 53: 686-692.
22. Chang Y, Ryu S, Suh BS, Yun KE, Kim CW, et al. (2012) Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. International journal of obesity 36: 1187-1194.
23. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic medicine: a journal of the British Diabetic Association 15: 539-553.
24. Mathiesen UL, Franzen LE, Aselius H, Resjo M, Jacobsson L, et al. (2002) Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 34: 516-522.
25. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
26. Wen CP, David Cheng TY, Tsai SP, Chan HT, Hsu HL, et al. (2009) Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr 12: 497-506.
27. WHO Western Pacific Region IaI The Asia-Pacific Perspective: Redefining Obesity and Its Treatment 2000. Health Communications Australia Pty Ltd Sydney, Australia.
28. Royston P, Parmar MK, (2002) Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 21: 2175-2197.
29. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, et al. (1990) Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 9: 1501-1515.
30. Maison P, Byrne CD, Hales CN, Day NE, Wareham NJ, (2001) Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care 24: 1758-1763.
31. Palaniappan L, Carnethon MR, Wang Y, Hanley AJ, Fortmann SP, et al. (2004) Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 27: 788-793.
32. Anderson JW, Kendall CW, Jenkins DJ, (2003) Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. Journal of the American College of Nutrition 22: 331-339.
33. Sesti G, Folli F, Perego L, Hribal ML, Pontiroli AE, (2011) Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PLoS One 6: e17737.
34. Rasouli N, Kern PA, (2008) Adipocytokines and the metabolic complications of obesity. The Journal of clinical endocrinology and metabolism 93: S64-73.
35. Antuna-Puente B, Feve B, Fellahi S, Bastard JP, (2008) Adipokines: the missing link between insulin resistance and obesity. Diabetes & metabolism 34: 2-11.
36. Lee YH, Magkos F, Mantzoros CS, Kang ES, (2011) Effects of leptin and adiponectin on pancreatic beta-cell function. Metabolism: clinical and experimental 60: 1664-1672.
37. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, et al. (2007) Adipokines oversecreted by omental adipose tissue in human obesity. American journal of physiology Endocrinology and metabolism 293: E656-665.
38. Lang HF, Chou CY, Sheu WH, Lin JY, (2011) Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m(2). Nutrition research 31: 378-386.
39. Klimcakova E, Kovacikova M, Stich V, Langin D, (2010) Adipokines and dietary interventions in human obesity. Obesity reviews: an official journal of the International Association for the Study of Obesity 11: 446-456.
40. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England journal of medicine 334: 292-295.
41. Esteve E, Ricart W, Fernandez-Real JM, (2009) Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes care 32Suppl 2: S362-367.
42. Iniguez G, Soto N, Avila A, Salazar T, Ong K, et al. (2004) Adiponectin levels in the first two years of life in a prospective cohort: relations with weight gain, leptin levels and insulin sensitivity. The Journal of clinical endocrinology and metabolism 89: 5500-5503.
43. Lankinen M, Schwab U, Kolehmainen M, Paananen J, Poutanen K, et al. (2011) Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study. PLoS One 6: e22646.